PubRank

Paulette Mhawech-Fauceglia

Author PubWeight™ 45.36‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc Natl Acad Sci U S A 2010 3.12
2 Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer. Proc Natl Acad Sci U S A 2007 2.61
3 Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients. Proc Natl Acad Sci U S A 2012 1.51
4 Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage. Clin Cancer Res 2011 1.38
5 Inhibition of urinary bladder carcinogenesis by broccoli sprouts. Cancer Res 2008 1.34
6 A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest 2013 1.33
7 Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer. Clin Cancer Res 2008 1.32
8 Challenges in array comparative genomic hybridization for the analysis of cancer samples. Genet Med 2007 1.14
9 Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer. Cancer Res 2009 1.13
10 Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer. Int J Cancer 2009 1.12
11 Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood 2007 1.08
12 Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary. Int J Gynecol Pathol 2007 1.03
13 Pathogenesis of mediastinal paravertebral müllerian cysts of Hattori: developmental endosalpingiosis-müllerianosis. Int J Gynecol Pathol 2010 1.01
14 OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer. Int J Oncol 2006 1.01
15 Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. J Clin Pathol 2006 1.01
16 Induction of GST and NQO1 in cultured bladder cells and in the urinary bladders of rats by an extract of broccoli (Brassica oleracea italica) sprouts. J Agric Food Chem 2006 1.01
17 Ewing sarcoma/primitive neuroectodermal tumor of the kidney: a case report. Diagnosed by immunohistochemistry and molecular analysis. Ann Diagn Pathol 2006 1.00
18 BRCAness profile of sporadic ovarian cancer predicts disease recurrence. PLoS One 2012 0.99
19 Gynecological malignancies in Maroua, Cameroon. Int J Gynaecol Obstet 2008 0.97
20 Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes. Transl Oncol 2009 0.97
21 Elevated expression of the serine-arginine protein kinase 1 gene in ovarian cancer and its role in Cisplatin cytotoxicity in vitro. PLoS One 2012 0.93
22 Malignant mixed müllerian tumor of primary peritoneal origin. Ann Diagn Pathol 2010 0.90
23 The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: a case report. Gynecol Oncol 2008 0.89
24 AKT inhibition mitigates GRP78 (glucose-regulated protein) expression and contribution to chemoresistance in endometrial cancers. Int J Cancer 2013 0.89
25 Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer. Cancer Immun 2009 0.89
26 Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors. Int J Gynecol Pathol 2007 0.89
27 5,6-Dihydrocyclopenta[c][1,2]-dithiole-3(4H)-thione is a promising cancer chemopreventive agent in the urinary bladder. Chem Biol Interact 2008 0.87
28 Histologic parameters predictive of disease outcome in women with advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy. Transl Oncol 2012 0.86
29 Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells. Clin Cancer Res 2007 0.85
30 Aldolase mRNA expression in endometrial cancer and the role of clotrimazole in endometrial cancer cell viability and morphology. Histopathology 2011 0.85
31 Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006. Gynecol Oncol 2009 0.84
32 Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery. Int J Gynecol Pathol 2011 0.83
33 Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis. Cancer Epidemiol Biomarkers Prev 2009 0.83
34 Epithelioid sarcoma of the vulva in a 17-year-old pregnant woman. Appl Immunohistochem Mol Morphol 2009 0.82
35 Pax-8 is a reliable marker in making the diagnosis in advanced stage epithelial ovarian carcinoma and primary peritoneal carcinoma for neoadjuvant chemotherapy on cell block and biopsy specimens. Histopathology 2012 0.82
36 DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer. Epigenetics 2015 0.81
37 Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer. Obstet Gynecol 2007 0.81
38 NPPB is a novel candidate biomarker expressed by cancer-associated fibroblasts in epithelial ovarian cancer. Int J Cancer 2014 0.80
39 Desmoplastic small round cell tumor (DSRCT) with ovarian involvement in 2 young women. Appl Immunohistochem Mol Morphol 2008 0.79
40 Primary vaginal adenocarcinoma arising in vaginal adenosis after CO2 laser vaporization and 5-fluorouracil therapy. Int J Gynecol Pathol 2010 0.78
41 Clinically aggressive primary solid pseudopapillary tumor of the ovary in a 45-year-old woman. Ann Diagn Pathol 2011 0.78
42 Microsatellite instability in large cell neuroendocrine carcinoma of the female genital tract. Histopathology 2009 0.77
43 Expression of poly (adenosine diphosphate-ribose) polymerase and p53 in epithelial ovarian cancer and their role in prognosis and disease outcome. Int J Gynecol Pathol 2011 0.75
44 Developmentally restricted differentiation antigens are targets for immunotherapy in epithelial ovarian carcinoma. Int J Gynecol Pathol 2013 0.75
45 Metastatic Acinic Cell Carcinoma to the Vagina: A First Reported Case. Appl Immunohistochem Mol Morphol 2017 0.75
46 Endometrioid Adenocarcinoma Arising in a Paratubal Cyst: A Case Report and Review of the Literature. Appl Immunohistochem Mol Morphol 2017 0.75
47 No association of NAD(P)H quinone oxidoreductase 1 expression with p53 expression or tumour outcome in patients with superficial and minimally invasive urothelial bladder cancers. BJU Int 2008 0.75
48 Ovarian yolk sac tumor associated with major fibrosarcoma component in a 13-year-old girl. Int J Gynecol Pathol 2010 0.75